Key Market Drivers – Fueling Growth in Cancer Research
Several powerful drivers are propelling the Global LGR5 Antibody Market forward. First, the increasing prevalence of cancer is a primary driver. According to the World Health Organization (WHO), cancer cases rose from 18.1 million in 2018 to approximately 19.3 million in 2020. With the rising incidence of colorectal, breast, and gastric cancers—which express...
0 Comentários 0 Compartilhamentos 1740 Visualizações